The Global Dengue & Aedes-Transmitted Diseases Consortium (GDAC) convened a 2-day consultative meeting of the Asia-Pacific Dengue Prevention Board on June 22-23, 2017 in Bangkok, Thailand.

The objective of this meeting was to define key issues and considerations in dengue prevention and control in the context of dengue and Zika co-circulation; and to provide recommendations for research and public health measures needed especially for the Asia-Pacific region. The meeting was sponsored by Bill & Melinda Gates Foundation, Sanofi Pasteur, Takeda Pharmaceuticals International AG, and Standard Diagnostics, Inc. (SD).

Download the meeting report

"> The Global Dengue & Aedes-Transmitted Diseases Consortium (GDAC) convened a 2-day consultative meeting of the Asia-Pacific Dengue Prevention Board on June 22-23, 2017 in Bangkok, Thailand.

The objective of this meeting was to define key issues and considerations in dengue prevention and control in the context of dengue and Zika co-circulation; and to provide recommendations for research and public health measures needed especially for the Asia-Pacific region. The meeting was sponsored by Bill & Melinda Gates Foundation, Sanofi Pasteur, Takeda Pharmaceuticals International AG, and Standard Diagnostics, Inc. (SD).

Download the meeting report

" /> Asia-Pacific Dengue Prevention Board Meeting 2017 - Global Dengue & Aedes-Transmitted Diseases Consortium (GDAC)

  • news

    Asia-Pacific Dengue Prevention Board Meeting 2017

Back

June 22-23, 2017 - Bangkok (Thailand)

The Global Dengue & Aedes-Transmitted Diseases Consortium (GDAC) convened a 2-day consultative meeting of the Asia-Pacific Dengue Prevention Board on June 22-23, 2017 in Bangkok, Thailand.

The objective of this meeting was to define key issues and considerations in dengue prevention and control in the context of dengue and Zika co-circulation; and to provide recommendations for research and public health measures needed especially for the Asia-Pacific region. The meeting was sponsored by Bill & Melinda Gates Foundation, Sanofi Pasteur, Takeda Pharmaceuticals International AG, and Standard Diagnostics, Inc. (SD).

Download the meeting report

Back to the list